Search research articles
Contact Us
Filters
Showing results (151-160 of 157) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 157 results.
Cell Reports
|
December 8, 2016
Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome
Xian Liu, Tristan R Grogan, Haley Hieronymus, et al.
Cancer & Metabolism
|
September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup></sup>
Jack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
OGDHL regulates nucleotide metabolism, tumor growth, and neuroendocrine marker expression in prostate cancer
Matthew J Bernard, Angel Ruiz, Johnny A Diaz, et al.
Nature Cell Biology
|
December 4, 2023
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment
Jenna M Giafaglione, Preston D Crowell, Amelie M L Delcourt, et al.
Cell Reports
|
October 10, 2023
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer
Preston D Crowell, Jenna M Giafaglione, Anthony E Jones, et al.
Molecular Cancer Research : MCR
|
January 27, 2026
OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance
Matthew J Bernard, Andrea Gallardo, Angel Ruiz, et al.
Neurobiology of Aging
|
August 11, 2020
PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan
Kensuke Daida, Kenya Nishioka, Yuanzhe Li, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 157) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 157 results.
Cell Reports
|
December 8, 2016
Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome
Xian Liu, Tristan R Grogan, Haley Hieronymus, et al.
Cancer & Metabolism
|
September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup></sup>
Jack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
OGDHL regulates nucleotide metabolism, tumor growth, and neuroendocrine marker expression in prostate cancer
Matthew J Bernard, Angel Ruiz, Johnny A Diaz, et al.
Nature Cell Biology
|
December 4, 2023
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment
Jenna M Giafaglione, Preston D Crowell, Amelie M L Delcourt, et al.
Cell Reports
|
October 10, 2023
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer
Preston D Crowell, Jenna M Giafaglione, Anthony E Jones, et al.
Molecular Cancer Research : MCR
|
January 27, 2026
OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance
Matthew J Bernard, Andrea Gallardo, Angel Ruiz, et al.
Neurobiology of Aging
|
August 11, 2020
PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan
Kensuke Daida, Kenya Nishioka, Yuanzhe Li, et al.
Page
of 16